Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Scaffold Therapeutics logo — Drug discovery in mRNA modification

Scaffold Therapeutics

Drug discovery in mRNA modification

Founded 2022 United States Boston, United States 3 employees Seed Biotechnology

General Information

Company Name Scaffold Therapeutics
Founded Year 2022
Location United States Boston, United States
Employees 3
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Scaffold Therapeutics. To contact Scaffold Therapeutics, visit scaffoldtx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Scaffold Therapeutics

Scaffold Therapeutics is a biotechnology startup founded in 2022 with the slogan "Drug discovery in mRNA modification." The company is focused on leveraging generative AI models to develop small molecules that regulate pathogenic mRNA activity. In January 2024, Scaffold Therapeutics secured a Seed Round investment from Iaso Ventures. The company is based in the United States. With its innovative approach to drug discovery and mRNA modification, Scaffold Therapeutics has attracted the attention of venture capital firms like Iaso Ventures, opening up opportunities for further growth and development in the biotechnology industry.

Taxonomy: Drug Discovery, mRNA Modification, Scaffold Therapeutics, Generative AI, Small Molecules, Regulation Technology, Pathogenic mRNA, AI Models, Therapeutics, Pharmaceuticals, Innovation, Research and Development, Bioscience

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Iaso Ventures
Iaso Ventures
01 Jan 2024

Scaffold Therapeutics Alternatives & Competitors

View All Alternatives
Scaffold Therapeutics vs
Orbit Discovery
Orbit Discovery United Kingdom

Delivering Peptide Enabled Drug Discovery Solutions

Seed
31 employees
Biotechnology, Health Care
Scaffold Therapeutics vs
Terray Therapeutics
Terray Therapeutics United States

Everything small molecule drug discovery should be.

Series B
142 employees
AI, Biopharma
Scaffold Therapeutics vs
EOLO PHARMA
EOLO PHARMA United States

Cutting-Edge Pharmacological Treatment for Obesity

Venture round
12 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Scaffold Therapeutics

Drug discovery in mRNA modification
Scaffold Therapeutics was founded in 2022.
Scaffold Therapeutics is headquartered in Boston, United States.
Scaffold Therapeutics operates in Biotechnology. Its work centres on Drug Discovery, mRNA Modification, Scaffold Therapeutics and Generative AI.
Scaffold Therapeutics has approximately 3 employees.
Scaffold Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Scaffold Therapeutics include Orbit Discovery, Terray Therapeutics, EOLO PHARMA, Exo Therapeutics, Design Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Scaffold Therapeutics and Orbit Discovery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Scaffold Therapeutics, https://bouncewatch.com/company/scaffold-therapeutics, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes